Today had discussions on some aggressive cancers and the two in particular are inflammatory breast cancer, which is when breast cancer affects what we call dermal lymphatics. So it’s a widespread cancer already at the time of diagnosis. Not common but very significant and very clinically impactful when it happens.
The other type, the other conversation, was on what we call triple negative breast cancer and that is a particular molecular subtype of cancer that’s known to be aggressive and known to be affecting young women preferentially. Those are often dramatic cases and having the privilege of coming from a cancer centre we have a lot of experience with that. I was happy to have the opportunity to share the experience.